Atlas Trials

Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes

Clinical trial NCT06991829 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06991829
Sponsor
Shanghai Zhongshan Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2025-04-03
Primary completion
2027-04-03
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.